These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 4449632)

  • 1. Plasma testosterone in advanced breast cancer.
    Horn H; Gordan GS
    Oncology; 1974; 30(2):147-51. PubMed ID: 4449632
    [No Abstract]   [Full Text] [Related]  

  • 2. [Blood levels of testosterone and dihydrotestosterone in breast cancer].
    Vitola GIa; Zeĭkate GA
    Vopr Onkol; 1976; 22(8):26-30. PubMed ID: 997415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on apparent free cortisol and testosterone in plasma from patients with breast tumours.
    Jones MK; Dyer GI; Ramsay ID; Collins WP
    Postgrad Med J; 1981 Feb; 57(664):89-94. PubMed ID: 7267513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of treatment with tamoxifen on serum levels of various steroid and protein hormones in women with breast cancer].
    Grodecka-Gazdecka S; Kociałkowski K; Chwalisz K; Baron J
    Endokrynol Pol; 1985; 36(6):341-8. PubMed ID: 3833535
    [No Abstract]   [Full Text] [Related]  

  • 5. Testosterone levels in the plasma of normal women and patients with benign breast disease or with breast cancer.
    Wang DY; Hayward JL; Bulbrook RD
    Eur J Cancer (1965); 1966 Dec; 2(4):373-6. PubMed ID: 5980828
    [No Abstract]   [Full Text] [Related]  

  • 6. Androgen-estrogen production rates in postmenopausal women with breast cancer.
    Kirschner MA; Cohen FB; Ryan C
    Cancer Res; 1978 Nov; 38(11 Pt 2):4029-35. PubMed ID: 568029
    [No Abstract]   [Full Text] [Related]  

  • 7. Plasma testosterone and breast cancer.
    Hill P; Garbaczewski L; Kasumi F
    Eur J Cancer Clin Oncol; 1985 Oct; 21(10):1265-6. PubMed ID: 4076290
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of tamoxifen and stilboestrol on plasma hormone levels in postmenopausal women with advanced breast cancer.
    McFadyen IJ; Raab G; Forrest AP; Langlands AO; Stewart HJ; Roberts MM; Hamilton T; Golder MP; Groom GV; Griffiths K
    Clin Oncol; 1979 Sep; 5(3):251-6. PubMed ID: 387323
    [No Abstract]   [Full Text] [Related]  

  • 9. High testosterone and low progesterone circulating levels in premenopausal patients with hyperplasia and cancer of the breast.
    Secreto G; Recchione C; Fariselli G; Di Pietro S
    Cancer Res; 1984 Feb; 44(2):841-4. PubMed ID: 6537901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Buserelin therapy in postmenopausal patients with advanced breast carcinoma].
    Vici P; Veltri E; Carpano S; Di Lauro L; Lopez M
    Clin Ter; 1991 Feb; 136(3):195-9. PubMed ID: 1827382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Androgens and breast cancer in premenopausal women.
    Secreto G; Toniolo P; Pisani P; Recchione C; Cavalleri A; Fariselli G; Totis A; Di Pietro S; Berrino F
    Cancer Res; 1989 Jan; 49(2):471-6. PubMed ID: 2521298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution of estradiol and percentage of free testosterone in sera of Japanese women: preoperative breast cancer patients and normal controls.
    Takatani O; Kosano H; Okumoto T; Akamatsu K; Tamakuma S; Hiraide H
    J Natl Cancer Inst; 1987 Dec; 79(6):1199-204. PubMed ID: 3480371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study on plasma sex hormone levels in patients with breast cancer.
    Chen F; Wang SS; Dai QT; Xing LY; Lu WY; Yang WX; Wang ZG; Yao FY
    Chin Med J (Engl); 1985 Jul; 98(7):507-10. PubMed ID: 3932015
    [No Abstract]   [Full Text] [Related]  

  • 14. [Steroid receptor levels in human breast carcinomas in relation to serum hormone levels in postmenopausal patients (author's transl)].
    Reiner G; Bieglmayer C; Jakesz R; Kees A; Kolb R; Spona J
    Wien Klin Wochenschr; 1981 May; 93(11):339-42. PubMed ID: 6791390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Serum levels of prolactin, estradiol, testosterone and sex hormone-binding globulin in women with breast cancer treated with cytostatics and anti-estrogens].
    Grodecka-Gazdecka S; Baron J
    Ginekol Pol; 1986 Dec; 57(12):778-83. PubMed ID: 3570023
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical and endocrine effects of leuprorelin acetate in pre- and postmenopausal patients with advanced breast cancer.
    Dowsett M; Jacobs S; Aherne J; Smith IE
    Clin Ther; 1992; 14 Suppl A():97-103. PubMed ID: 1606596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated levels of circulating insulin-like growth factor-I, IGF-binding globulin-3 and testosterone predict hormone-dependent breast cancer in postmenopausal women: a case-control study.
    Kahán Z; Gardi J; Nyári T; Földesi I; Hajnal-Papp R; Ormándi K; Lázár G; Thurzó L; Schally AV
    Int J Oncol; 2006 Jul; 29(1):193-200. PubMed ID: 16773200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Twenty-four-hour preoperative endocrine profiles in women with benign and malignant breast disease.
    Malarkey WB; Schroeder LL; Stevens VC; James AG; Lanese RR
    Cancer Res; 1977 Dec; 37(12):4655-9. PubMed ID: 922746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptide and steroid hormone levels in pre- and postmenopausal breast carcinoma.
    Bhatavdekar JM; Shah NG; Trivedi SN; Karelia NH
    Neoplasma; 1987; 34(1):95-9. PubMed ID: 3104809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endocrine status in stage II vs. advanced premenopausal and postmenopausal breast cancer patients.
    Bhatavdekar JM; Patel DD; Shah NG; Giri DD; Vora HH; Karelia NH; Trivedi SN; Ghosh N; Suthar TP
    Neoplasma; 1992; 39(1):39-42. PubMed ID: 1388248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.